目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market 2018 - 2022
Historic Market Size - Data Table on Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Chart on Oncology - Year-over-year growth 2023-2028 (%)
Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Ophthalmology - Market size and forecast 2023-2028
Chart on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Data Table on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Chart on Ophthalmology - Year-over-year growth 2023-2028 (%)
Data Table on Ophthalmology - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 VEGF-A inhibitor - Market size and forecast 2023-2028
Chart on VEGF-A inhibitor - Market size and forecast 2023-2028 ($ million)
Data Table on VEGF-A inhibitor - Market size and forecast 2023-2028 ($ million)
Chart on VEGF-A inhibitor - Year-over-year growth 2023-2028 (%)
Data Table on VEGF-A inhibitor - Year-over-year growth 2023-2028 (%)
7.4 VEGF-B inhibitor - Market size and forecast 2023-2028
Chart on VEGF-B inhibitor - Market size and forecast 2023-2028 ($ million)
Data Table on VEGF-B inhibitor - Market size and forecast 2023-2028 ($ million)
Chart on VEGF-B inhibitor - Year-over-year growth 2023-2028 (%)
Data Table on VEGF-B inhibitor - Year-over-year growth 2023-2028 (%)
7.5 VEGF-C inhibitor - Market size and forecast 2023-2028
Chart on VEGF-C inhibitor - Market size and forecast 2023-2028 ($ million)
Data Table on VEGF-C inhibitor - Market size and forecast 2023-2028 ($ million)
Chart on VEGF-C inhibitor - Year-over-year growth 2023-2028 (%)
Data Table on VEGF-C inhibitor - Year-over-year growth 2023-2028 (%)
7.6 VEGF-D inhibitor - Market size and forecast 2023-2028
Chart on VEGF-D inhibitor - Market size and forecast 2023-2028 ($ million)
Data Table on VEGF-D inhibitor - Market size and forecast 2023-2028 ($ million)
Chart on VEGF-D inhibitor - Year-over-year growth 2023-2028 (%)
Data Table on VEGF-D inhibitor - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc. - Overview
Regeneron Pharmaceuticals Inc. - Product / Service
Regeneron Pharmaceuticals Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Ophthalmology - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Ophthalmology - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Application ($ million)
Exhibits45: Data Table on Market opportunity by Application ($ million)
Exhibits46: Chart on Type - Market share 2023-2028 (%)
Exhibits47: Data Table on Type - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Type
Exhibits49: Data Table on Comparison by Type
Exhibits50: Chart on VEGF-A inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on VEGF-A inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on VEGF-A inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on VEGF-A inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on VEGF-B inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on VEGF-B inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on VEGF-B inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on VEGF-B inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on VEGF-C inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on VEGF-C inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on VEGF-C inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on VEGF-C inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on VEGF-D inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on VEGF-D inhibitor - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on VEGF-D inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on VEGF-D inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Type ($ million)
Exhibits67: Data Table on Market opportunity by Type ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape($ million)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: AstraZeneca Plc - Overview
Exhibits126: AstraZeneca Plc - Product / Service
Exhibits127: AstraZeneca Plc - Key news
Exhibits128: AstraZeneca Plc - Key offerings
Exhibits129: Bausch Health Companies Inc. - Overview
Exhibits130: Bausch Health Companies Inc. - Business segments
Exhibits131: Bausch Health Companies Inc. - Key news
Exhibits132: Bausch Health Companies Inc. - Key offerings
Exhibits133: Bausch Health Companies Inc. - Segment focus
Exhibits134: Bayer AG - Overview
Exhibits135: Bayer AG - Business segments
Exhibits136: Bayer AG - Key news
Exhibits137: Bayer AG - Key offerings
Exhibits138: Bayer AG - Segment focus
Exhibits139: Bristol Myers Squibb Co. - Overview
Exhibits140: Bristol Myers Squibb Co. - Product / Service
Exhibits141: Bristol Myers Squibb Co. - Key news
Exhibits142: Bristol Myers Squibb Co. - Key offerings
Exhibits143: Eisai Co. Ltd. - Overview
Exhibits144: Eisai Co. Ltd. - Business segments
Exhibits145: Eisai Co. Ltd. - Key offerings
Exhibits146: Eisai Co. Ltd. - Segment focus
Exhibits147: Eli Lilly and Co. - Overview
Exhibits148: Eli Lilly and Co. - Product / Service
Exhibits149: Eli Lilly and Co. - Key news
Exhibits150: Eli Lilly and Co. - Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. - Overview
Exhibits152: F. Hoffmann La Roche Ltd. - Business segments
Exhibits153: F. Hoffmann La Roche Ltd. - Key news
Exhibits154: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits155: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits156: Merck and Co. Inc. - Overview
Exhibits157: Merck and Co. Inc. - Business segments
Exhibits158: Merck and Co. Inc. - Key news
Exhibits159: Merck and Co. Inc. - Key offerings
Exhibits160: Merck and Co. Inc. - Segment focus
Exhibits161: Novartis AG - Overview
Exhibits162: Novartis AG - Business segments
Exhibits163: Novartis AG - Key news
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Regeneron Pharmaceuticals Inc. - Overview
Exhibits171: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits172: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits173: Sanofi SA - Overview
Exhibits174: Sanofi SA - Business segments
Exhibits175: Sanofi SA - Key news
Exhibits176: Sanofi SA - Key offerings
Exhibits177: Sanofi SA - Segment focus
Exhibits178: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Information sources
Exhibits187: Data validation
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Data synthesis
Exhibits190: 360 degree market analysis
Exhibits191: List of abbreviations